Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphoma
Maxime Battistella, Anne Janin, Francette Jean-Louis, et al.
British Journal of Dermatology (2016) Vol. 175, Iss. 2, pp. 325-333
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Advances in targeted therapy for malignant lymphoma
Li Wang, Wei Qin, Yujia Huo, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 102
Deciphering the killer‐cell immunoglobulin‐like receptor system at super‐resolution for natural killer and T‐cell biology
Vivien Béziat, Hugo G. Hilton, Paul J. Norman, et al.
Immunology (2016) Vol. 150, Iss. 3, pp. 248-264
Open Access | Times Cited: 77
Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome
Louise Photiou, Carrie Van Der Weyden, Christopher McCormack, et al.
Current Oncology Reports (2018) Vol. 20, Iss. 4
Closed Access | Times Cited: 57
A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders
Werner Kempf
Seminars in Diagnostic Pathology (2016) Vol. 34, Iss. 1, pp. 22-35
Closed Access | Times Cited: 52
Novel targeted therapies of T cell lymphomas
Katarzyna Iżykowska, Karolina Rassek, Dorota Korsak, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 48
CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies
Lucía Prieto‐Torres, Socorro María Rodríguez‐Pinilla, Arantza Onaindía, et al.
Haematologica (2019) Vol. 104, Iss. 2, pp. 226-235
Open Access | Times Cited: 47
Reduction of Relapse after Unrelated Donor Stem Cell Transplantation by KIR-Based Graft Selection
Silke Heidenreich, Nicolaus Kröger
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 40
Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell Culture
Sebastian Lunemann, Anja Schöbel, Janine Kah, et al.
Gastroenterology (2018) Vol. 155, Iss. 5, pp. 1366-1371.e3
Closed Access | Times Cited: 38
KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting
Maxime Battistella, Christophe Lebœuf, C. Ram‐Wolff, et al.
Blood (2017) Vol. 130, Iss. 26, pp. 2900-2902
Open Access | Times Cited: 38
Brentuximab vedotin in T-cell lymphoma
Carrie Van Der Weyden, Michael Dickinson, James C. Whisstock, et al.
Expert Review of Hematology (2018) Vol. 12, Iss. 1, pp. 5-19
Closed Access | Times Cited: 34
An Update on Molecular Biology of Cutaneous T Cell Lymphoma
Ritika Walia, Cecilia C.S. Yeung
Frontiers in Oncology (2020) Vol. 9
Open Access | Times Cited: 30
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides
Yun‐Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy
Joachim Koch, Michael Tesar
Transfusion Medicine and Hemotherapy (2017) Vol. 44, Iss. 5, pp. 337-350
Open Access | Times Cited: 22
Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas
Christian Schmitt, Anne Marie‐Cardine, Armand Bensussan
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 20
Low-dose total skin electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or Sezary syndrome
Khaled Elsayad, Kai Kroeger, Burkhard Greve, et al.
Strahlentherapie und Onkologie (2019) Vol. 196, Iss. 1, pp. 77-84
Closed Access | Times Cited: 19
Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome
Jenna Janiga, Jonathan Kentley, Chadi Nabhan, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2018) Vol. 59, Iss. 3, pp. 562-577
Closed Access | Times Cited: 15
KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target
Morgane Cheminant, Ludovic Lhermitte, Julie Bruneau, et al.
Blood (2022) Vol. 140, Iss. 13, pp. 1522-1532
Open Access | Times Cited: 8
IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma
Carrie Van Der Weyden, M. Bagot, Paul J. Neeson, et al.
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 8, pp. 691-697
Closed Access | Times Cited: 12
KIR3DL2 expression in patients with adult T-cell lymphoma/leukaemia
Charlotte Hurabielle, Christophe Lebœuf, C. Ram‐Wolff, et al.
British Journal of Dermatology (2018) Vol. 179, Iss. 1, pp. 197-199
Closed Access | Times Cited: 11
Clinical Guidelines and New Molecular Targets for Cutaneous Lymphomas
Makoto Sugaya
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11079-11079
Open Access | Times Cited: 6
The potentials of immune checkpoints for the treatment of blood malignancies
Mohsen Alizadeh, Ali Safarzadeh, Seyed Ali Hoseini, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 153, pp. 103031-103031
Closed Access | Times Cited: 5
Targeting KIR3DL2 in primary cutaneous anaplastic large cell lymphomas
Pablo L. Ortiz‐Romero
British Journal of Dermatology (2016) Vol. 175, Iss. 2, pp. 246-247
Closed Access | Times Cited: 1
Place de l’immunophénotypage sanguin et de l’étude de la clonalité dans la prise en charge des lymphomes T cutanés
Charlène Bouthemy, Asma Beldi‐Ferchiou, Nicolás Ortonne, et al.
Annales de Dermatologie et de Vénéréologie (2017) Vol. 144, Iss. 4, pp. 315-322
Closed Access | Times Cited: 1
Lymphomes cutanés primitifs : actualités thérapeutiques
O. Dereure
Annales de Dermatologie et de Vénéréologie (2019) Vol. 146, Iss. 2, pp. 92-99
Open Access | Times Cited: 1
Cytokines, Genetic Lesions and Signaling Pathways in Anaplastic Large Cell Lymphomas
Jean‐Philippe Merlio, Marshall E. Kadin
Cancers (2021) Vol. 13, Iss. 17, pp. 4256-4256
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top